These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20146218)
21. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801 [TBL] [Abstract][Full Text] [Related]
22. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease. Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122 [TBL] [Abstract][Full Text] [Related]
23. Therapy and outcome of orbital primitive neuroectodermal tumor. Bakhshi S; Meel R; Naqvi SG; Mohanti BK; Kashyap S; Pushker N; Sen S Pediatr Blood Cancer; 2009 Apr; 52(4):544-7. PubMed ID: 19090547 [TBL] [Abstract][Full Text] [Related]
24. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550 [TBL] [Abstract][Full Text] [Related]
25. Current treatment approaches for infants with malignant central nervous system tumors. Lafay-Cousin L; Strother D Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475 [TBL] [Abstract][Full Text] [Related]
26. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756 [TBL] [Abstract][Full Text] [Related]
27. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. Grodman H; Wolfe L; Kretschmar C Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417 [TBL] [Abstract][Full Text] [Related]
28. Primary intraspinal primitive neuroectodermal tumor treated with autologous stem cell transplantation: case report and review of the literature. Nutman A; Postovsky S; Zaidman I; Elhasid R; Vlodavsky E; Kreiss Y; Ben Arush MW Pediatr Hematol Oncol; 2007; 24(1):53-61. PubMed ID: 17130114 [TBL] [Abstract][Full Text] [Related]
29. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors. Marachelian A; Butturini A; Finlay J Bone Marrow Transplant; 2008 Jan; 41(2):167-72. PubMed ID: 18176620 [TBL] [Abstract][Full Text] [Related]
30. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814 [TBL] [Abstract][Full Text] [Related]
31. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study]. Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961 [TBL] [Abstract][Full Text] [Related]
32. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET. Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071 [TBL] [Abstract][Full Text] [Related]
33. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324 [TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Packer RJ Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331 [TBL] [Abstract][Full Text] [Related]
35. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas? Massimino M; Cohen KJ; Finlay JL Pediatr Blood Cancer; 2010 Apr; 54(4):641-3. PubMed ID: 20146219 [TBL] [Abstract][Full Text] [Related]
36. Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses. von Bueren AO; Warmuth-Metz M; Schlegel PG; Soerensen N; Krauss J; Roggendorf W; Pietsch T; Feiden W; Graf N; Pohl F; Flentje M; Kuehl J; Rutkowski S Pediatr Blood Cancer; 2011 Mar; 56(3):503-5. PubMed ID: 21113945 [No Abstract] [Full Text] [Related]
37. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806 [TBL] [Abstract][Full Text] [Related]
38. [CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report]. Sato H; Shibuya K; Koizumi T; Kato S; Endo S No Shinkei Geka; 2014 Jul; 42(7):641-50. PubMed ID: 25006105 [TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy and/or chemotherapy in children with primitive neuroectodermal tumor (PNET) of the pineal region]. Dunst J Strahlenther Onkol; 1996 Feb; 172(2):108-9. PubMed ID: 8669042 [No Abstract] [Full Text] [Related]